SARS-CoV-2 as RNA-virus activates cGAS– stimulator of interferon genes (STING) signaling in endothelial cells through mitochondrial DNA release, which leads to type I IFN production, and pharmacological inhibition of STING reduces severe lung inflammation and disease severity (Domizio et al. 2022). The gene discussed is STING1; the disease is inflammatory response.